amlodipine has been researched along with Psoriasis in 2 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the benefit of amlodipine, a calcium channel blocker, on renal function and vasoactive hormones in individuals with normal kidneys and blood pressure and who were being treated with cyclosporin A for refractory psoriasis." | 9.08 | Modifying effects of amlodipine on cyclosporin A-induced changes in renal function in patients with psoriasis. ( Albano, JD; Campbell, SK; Cook, J; Farrer, A; Raman, GV, 1998) |
| "To assess the benefit of amlodipine, a calcium channel blocker, on renal function and vasoactive hormones in individuals with normal kidneys and blood pressure and who were being treated with cyclosporin A for refractory psoriasis." | 5.08 | Modifying effects of amlodipine on cyclosporin A-induced changes in renal function in patients with psoriasis. ( Albano, JD; Campbell, SK; Cook, J; Farrer, A; Raman, GV, 1998) |
| " We present a patient with psoriasis and pemphigus foliaceus aggravated by enalapril and amlodipine intake, with successful response of both conditions to adalimumab therapy." | 3.85 | Pemphigus foliaceus worsened by drugs in a patient with psoriasis, responding to adalimumab. ( Caro-Gutiérrez, D; Gallo, E; Gutiérrez Pascual, M; Rojas-Scheffer, L; Sánchez-Gilo, A; Sanz-Bueno, J; Vicente-Martín, FJ, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sanz-Bueno, J | 1 |
| Gallo, E | 1 |
| Caro-Gutiérrez, D | 1 |
| Sánchez-Gilo, A | 1 |
| Gutiérrez Pascual, M | 1 |
| Rojas-Scheffer, L | 1 |
| Vicente-Martín, FJ | 1 |
| Raman, GV | 1 |
| Campbell, SK | 1 |
| Farrer, A | 1 |
| Albano, JD | 1 |
| Cook, J | 1 |
1 trial available for amlodipine and Psoriasis
| Article | Year |
|---|---|
Modifying effects of amlodipine on cyclosporin A-induced changes in renal function in patients with psoriasis.
Topics: Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Cyclosporine; Drug Therapy, Combi | 1998 |
1 other study available for amlodipine and Psoriasis
| Article | Year |
|---|---|
Pemphigus foliaceus worsened by drugs in a patient with psoriasis, responding to adalimumab.
Topics: Adalimumab; Amlodipine; Anti-Inflammatory Agents; Antihypertensive Agents; Enalapril; Humans; Male; | 2017 |